Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1131 Neoplasms 986 Carcinoma, Non-Small-Cell Lung 903 Prostatic Neoplasms 595 Neoplasm Metastasis 529 Leukemia, Myeloid, Acute 514 Colorectal Neoplasms 492 Lung Neoplasms 490 Melanoma 488 Multiple Myeloma 478 Pancreatic Neoplasms 387 Lymphoma 370 Ovarian Neoplasms 368 Recurrence 365 Lymphoma, Non-Hodgkin 348 Leukemia 340 Leukemia, Lymphocytic, Chronic, B-Cell 322 Precursor Cell Lymphoblastic Leukemia-Lymphoma 291 Head and Neck Neoplasms 276 Carcinoma, Renal Cell 276 Brain Neoplasms 276 Carcinoma, Hepatocellular 261 Glioblastoma 250 Myelodysplastic Syndromes 244 Lymphoma, Large B-Cell, Diffuse 244 Squamous Cell Carcinoma of Head and Neck 241 Lymphoma, Follicular 236 Colonic Neoplasms 214 Stomach Neoplasms 200 Rectal Neoplasms 190

Interventions

glembatumumab vedotin 1 CR011-vcMMAE 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Squamous Cell Carcinoma of the Lung × Clear all

NCT02713828 2019-07-16

PrE0504

PrECOG, LLC.

Phase 1/2 Terminated

13 enrolled 12 charts

Squamous Cell Carcinoma of the Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡